Serum Levels and Clinical Significance of NSE, BDNF and CNTF in Patients with Cancer-associated Ischemic Stroke Complicated with Post-stroke Depression
Actas Españolas de Psiquiatría · 2024
DOI: 10.62641/aep.v52i4.1667 ↗Kurz gefasst
Fachartikel in der Zeitschrift Actas Españolas de Psiquiatría, 2024. Verfasst von Baigui Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Zhejiang Jinhua Guangfu Oncology Hospital, 321000 Jinhua, Zhejiang, China. Hauptthemen laut MEDLINE: Brain-Derived Neurotrophic Factor, Phosphopyruvate Hydratase, Ischemic Stroke, Depression. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Depression, Schlaganfall
Abstract (Originalsprache)
Background
The incidence of post-stroke depression (PSD) may be higher in patients with cancer-associated ischemic stroke (CAIS). The pathogenesis of PSD is mainly related to the emotional injury of stroke and the inability of neurons to effectively repair. This study aims to explore the clinical significance of serum neuron-specific enolase (NSE), brain-derived neurotrophic factor (BDNF) and ciliary neurotrophic factor (CNTF) expression levels in CAIS patients.
Methods
Clinical data of 106 patients with CAIS admitted to Jinhua Guangfu Oncology Hospital from January 2012 to December 2022 were retrospectively analyzed. Serum levels of NSE, BDNF and CNTF were measured in all patients after admission. Depression screening was performed by Hamilton Depression Scale-17 (HAMD-17) three months after intravenous thrombolysis. Patients with HAMD-17 score >7 were included in the PSD group (n = 44), and patients with HAMD-17 score ≤7 were included in the non-PSD group (n = 62). The general data and serum levels of NSE, BDNF and CNTF were compared between the two groups. According to HAMD-17 scores, patients in PSD group were further divided into mild depression group (8–16 points), moderate depression group (17–23 points) and severe depression group (≥24 points), and the serum levels of NSE, BDNF and CNTF were compared among the three groups. Pearson's correlation test was used to analyze the correlation between HAMD-17 scores and serum NSE, BDNF and CNTF levels in PSD patients. Logistic regression model was used to determine the influencing factors of PSD in CAIS patients. Receiver operating characteristic (ROC) curve was plotted to analyze the predictive efficacy of serum NSE, BDNF, CNTF and their combination on PSD.
Results
Among 106 CAIS patients, the incidence of PSD was 41.51% (44 cases), including 19 patients with mild PSD (43.18%), 14 patients with moderate PSD (31.82%), and 11 patients with severe PSD (25.00%). There were statistically significant differences in negative life events and complications after thrombolytic therapy between PSD and non-PSD patients (p < 0.05). The serum NSE level in PSD group was significantly higher than that in non-PSD group, and the serum BDNF and CNTF levels were notably lower than those in non-PSD group (all p < 0.001). The serum levels of NSE, BDNF and CNTF in patients with different severity of PSD were statistically significant (all p < 0.001). HAMD-17 scores in PSD patients were positively correlated with serum NSE levels (r = 0.676, p < 0.001) and negatively correlated with serum BDNF and CNTF levels (r = –0.661, p < 0.001; r = –0.401, p = 0.007, respectively). By binary logistic regression analysis, the levels of serum NSE, BDNF and CNTF were independent influencing factors for PSD in CAIS patients, among which NSE was a risk factor (odds ratio (OR) >1, p < 0.05), BDNF and CNTF were protective factors (OR
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Zhejiang Jinhua Guangfu Oncology Hospital, 321000 Jinhua, Zhejiang, China.
- Department of Respiratory Oncology, Zhejiang Jinhua Guangfu Oncology Hospital, 321000 Jinhua, Zhejiang, China.
- Department of Emergency, Zhejiang Jinhua Guangfu Oncology Hospital, 321000 Jinhua, Zhejiang, China.
Zitieren
APA
Zhou, B., Mu, K., Yu, X., & Shi, X. (2024). Serum Levels and Clinical Significance of NSE, BDNF and CNTF in Patients with Cancer-associated Ischemic Stroke Complicated with Post-stroke Depression. Actas Españolas de Psiquiatría. https://doi.org/10.62641/aep.v52i4.1667
Vancouver
Zhou B, Mu K, Yu X, Shi X. Serum Levels and Clinical Significance of NSE, BDNF and CNTF in Patients with Cancer-associated Ischemic Stroke Complicated with Post-stroke Depression. Actas Españolas de Psiquiatría. 2024. doi:10.62641/aep.v52i4.1667
BibTeX
@article{Zhou2024,
author = {Zhou, Baigui and Mu, Kun and Yu, Xuzhou and Shi, Xiaoying},
title = {Serum Levels and Clinical Significance of NSE, BDNF and CNTF in Patients with Cancer-associated Ischemic Stroke Complicated with Post-stroke Depression},
journal = {Actas Españolas de Psiquiatría},
year = {2024},
doi = {10.62641/aep.v52i4.1667}
}
EUVIMED